These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3809521)
21. Effects of barbital and lorazepam in the AT and ANT rats: motor performance and brain monoamine functions. Hellevuo K; Kiianmaa K; Juhakoski A Alcohol Alcohol Suppl; 1987; 1():647-51. PubMed ID: 2447906 [TBL] [Abstract][Full Text] [Related]
22. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine. Van Ree JM; Innemee H; Louwerens JW; Kahn RS; De Wied D Neuropharmacology; 1982 Nov; 21(11):1095-101. PubMed ID: 6184639 [TBL] [Abstract][Full Text] [Related]
23. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration. Stolman S; Loh HH Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916 [TBL] [Abstract][Full Text] [Related]
24. The effects of chronic oral administration of barbital on cerebellar cyclic GMP. Lane SJ; Morgan WW Neuropharmacology; 1984 Jul; 23(7A):779-83. PubMed ID: 6089024 [TBL] [Abstract][Full Text] [Related]
25. Intracerebroventricular apomorphine alleviates spontaneous forgetting and increases cortical noradrenaline. Sara SJ; Grecksch G; Leviel V Behav Brain Res; 1984 Jul; 13(1):43-52. PubMed ID: 6477718 [TBL] [Abstract][Full Text] [Related]
26. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats. Weiss F; Ettenberg A; Koob GF Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480 [TBL] [Abstract][Full Text] [Related]
27. Differences in the stereotypy response but not the hypomotility response to apomorphine in the Roman High and Low avoiding strains of rats. Durcan MJ; Fulker DW; Campbell IC Psychopharmacology (Berl); 1984; 82(3):215-20. PubMed ID: 6425902 [TBL] [Abstract][Full Text] [Related]
28. Effects of ethanol, barbital, and lorazepam on brain monoamines in rat lines selectively outbred for differential sensitivity to ethanol. Hellevuo K; Kiianmaa K Pharmacol Biochem Behav; 1988 Jan; 29(1):183-8. PubMed ID: 3353424 [TBL] [Abstract][Full Text] [Related]
29. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Spyraki C; Fibiger HC Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991 [TBL] [Abstract][Full Text] [Related]
30. The influence of the tricyclic antidepressants on the apomorphine induced hypermotility in rats. Grabowska M; Antikiewicz L; Michaluk J Pol J Pharmacol Pharm; 1974; 26(4):411-7. PubMed ID: 4416321 [No Abstract] [Full Text] [Related]
31. Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats. Jänicke UA; Coper H Drug Alcohol Depend; 1984 Jan; 13(1):43-54. PubMed ID: 6539666 [TBL] [Abstract][Full Text] [Related]
32. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems. Van Ree JM; Elands J; Király I; Wolterink G Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429 [TBL] [Abstract][Full Text] [Related]
33. The involvement of serotonin in the mechanism of central action of apomorphine. Grabowska M Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347 [TBL] [Abstract][Full Text] [Related]
35. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum. Gerhards HJ; Carenzi A; Costa E Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258 [No Abstract] [Full Text] [Related]
36. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306 [TBL] [Abstract][Full Text] [Related]
37. Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs. Durlach-Misteli C; Van Ree JM Eur J Pharmacol; 1992 Jun; 217(1):15-21. PubMed ID: 1397023 [TBL] [Abstract][Full Text] [Related]
38. Tolerance to ethanol and cross-tolerance to pentobarbital and barbital. Gougos A; Khanna JM; Lê AD; Kalant H Pharmacol Biochem Behav; 1986 Apr; 24(4):801-7. PubMed ID: 3714775 [TBL] [Abstract][Full Text] [Related]
39. Pharmacologic effects of apomorphine in rats with altered level of brain serotonin. Grabowska M; Michaluk J; Antkiewicz L Arch Immunol Ther Exp (Warsz); 1975; 23(4):517-26. PubMed ID: 126051 [TBL] [Abstract][Full Text] [Related]
40. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]